Biotalys NV Statistics

Total Valuation

Biotalys NV has a market cap or net worth of EUR 110.13 million. The enterprise value is 100.93 million.

Market Cap	110.13M
Enterprise Value	100.93M

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Biotalys NV has 37.46 million shares outstanding. The number of shares has increased by 3.62% in one year.

Current Share Class	n/a
Shares Outstanding	37.46M
Shares Change (YoY)	+3.62%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	5.89%
Float	10.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	4.83
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.18
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.12

Financial Position

The company has a current ratio of 3.88, with a Debt / Equity ratio of 0.28.

Current Ratio	3.88
Quick Ratio	3.29
Debt / Equity	0.28
Debt / EBITDA	n/a
Debt / FCF	-0.33
Interest Coverage	-126.79

Financial Efficiency

Return on equity (ROE) is -59.66% and return on invested capital (ROIC) is -31.17%.

Return on Equity (ROE)	-59.66%
Return on Assets (ROA)	-27.07%
Return on Capital (ROIC)	-31.17%
Revenue Per Employee	n/a
Profits Per Employee	-217,800
Employee Count	75
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +20.73% in the last 52 weeks. The beta is 0.96, so Biotalys NV's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	+20.73%
50-Day Moving Average	3.13
200-Day Moving Average	3.08
Relative Strength Index (RSI)	38.67
Average Volume (20 Days)	11,510

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-16.61M
Pretax Income	-16.23M
Net Income	-16.34M
EBITDA	-15.09M
EBIT	-16.61M
Earnings Per Share (EPS)	-0.51

Full Income Statement

Balance Sheet

The company has 14.68 million in cash and 5.49 million in debt, giving a net cash position of 9.20 million or 0.25 per share.

Cash & Cash Equivalents	14.68M
Total Debt	5.49M
Net Cash	9.20M
Net Cash Per Share	0.25
Equity (Book Value)	19.58M
Book Value Per Share	0.61
Working Capital	13.70M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -16.29 million and capital expenditures -210,000, giving a free cash flow of -16.50 million.

Operating Cash Flow	-16.29M
Capital Expenditures	-210,000
Free Cash Flow	-16.50M
FCF Per Share	-0.44

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biotalys NV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.62%
Shareholder Yield	-3.62%
Earnings Yield	-17.32%
FCF Yield	-14.99%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a